IMO, I think it may take longer than we think to get enough data from cancer for a BO and/or approval. Enrollment seems to take a number of weeks or months and after that process the patient may not even be eligible for leronlimab (not CCR5 +). NP has said they have many interested, but many of those interested aren’t for the mTNBC trial but for the emergency IND.